ProjektAspergillosis – Multimodal preclinical imaging of Aspergillus fumigatus invasion and treatment
Grunddaten
Akronym:
Aspergillosis
Titel:
Multimodal preclinical imaging of Aspergillus fumigatus invasion and treatment
Laufzeit:
01.05.2023 bis 30.04.2026
Abstract / Kurz- beschreibung:
Aspergillus fumigatus (A. fumigatus) is a ubiquitous mold, whose airborne spores are frequently
inhaled. While immunocompetent people do not suffer from a related infection, people with a
compromised immune system frequently develop an invasive infection from the lungs resulting from inhalation of A.
fumigatus, termed invasive Aspergillosis (IA). To address this clinical need, the use of targeted contrast agents for molecular imaging
techniques such as Positron Emission Tomography (PET) or Single Photon Emission
Tomography (SPECT) could provide an efficient solution.
inhaled. While immunocompetent people do not suffer from a related infection, people with a
compromised immune system frequently develop an invasive infection from the lungs resulting from inhalation of A.
fumigatus, termed invasive Aspergillosis (IA). To address this clinical need, the use of targeted contrast agents for molecular imaging
techniques such as Positron Emission Tomography (PET) or Single Photon Emission
Tomography (SPECT) could provide an efficient solution.
Beteiligte Mitarbeiter/innen
Leiter/innen
Medizinische Fakultät
Universität Tübingen
Universität Tübingen
Lokale Einrichtungen
Abteilung Präklinische Bildgebung und Radiopharmazie
Radiologische Universitätsklinik (Department)
Kliniken und klinische Institute, Medizinische Fakultät
Kliniken und klinische Institute, Medizinische Fakultät
Geldgeber
Bonn, Nordrhein-Westfalen, Deutschland